Radiation Oncology/Therapy: Page 192

Elekta sells 2 Infinity rad therapy systems
By AuntMinnie.com staff writers
Radiation oncology firm Elekta has sold two Elekta Infinity radiation therapy systems to Banner MD Anderson Cancer Center in Gilbert, AZ.
February 6, 2013
AMIC submits RadioGel data to FDA
By AuntMinnie.com staff writers
Medical isotope producer Advanced Medical Isotope (AMIC) has submitted data on its RadioGel device to the U.S. Food and Drug Administration and requested a collaborative meeting.
February 6, 2013
Revenue decline hurts Accuray Q2 results
By AuntMinnie.com staff writers
A decrease in product revenue adversely affected financial results for radiation oncology firm Accuray in the second quarter of the company's 2013 fiscal year.
February 6, 2013
Accelerated RT with boost works well for breast cancer patients
By Cynthia E. Keen
Accelerated whole-breast radiation therapy (RT), which shortens radiation treatment duration by half, is proved to be as effective as conventional therapy for early-stage breast cancer patients. Whether a concomitant boost is needed remains a subject of debate among radiation oncologists due to the overall treatment's potential toxicity.
February 5, 2013
Accuray reports 1st patient treated with CyberKnife M6
By AuntMinnie.com staff writers
Radiation oncology firm Accuray said that the first patient worldwide has been treated with its new CyberKnife M6 system.
February 4, 2013
ViewRay names new president/CEO
By AuntMinnie.com staff writers
Image-guided therapy developer ViewRay has named Chris Raanes as its president and CEO effective immediately.
February 4, 2013
WSJ: 'Fiscal cliff' payment change benefits Varian
By AuntMinnie.com staff writers
An unanticipated provision in the congressional budget bill addressing the U.S. "fiscal cliff" included a financial and competitive advantage for radiation therapy firm Varian Medical Systems, according to a Wall Street Journal article published on January 28.
January 31, 2013
AuntMinnie.com Radiation Oncology Insider
By Cynthia E. Keen
January 31, 2013
PET/CT predicts response to endorectal radiotherapy
By Eric Barnes
PET/CT results can predict which patients will respond to high-dose-rate endorectal brachytherapy for stage II and III rectal cancer, according to a study presented at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium. The results could pave the way for easier treatments and better outcomes.
January 29, 2013
2013 01 30 11 48 12 369 Kumar Petct 450 20130130185319
Intio unveils SyncView
By AuntMinnie.com staff writers
Interventional oncology technology developer Intio has introduced SyncView, a software feature that allows interventional oncologists to view a segmented target lesion during CT-guided ablation procedures in conjunction with the post-treatment ablation zone.
January 29, 2013
Blacks treated less, die sooner from advanced colon cancer
By Eric Barnes
When it comes to advanced metastatic colorectal cancer, blacks are less likely to be referred for treatment, less likely to receive it, and more likely to die sooner than whites, according to a study presented on Saturday at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium.
January 28, 2013
Sirtex touts studies at ASCO symposium
By AuntMinnie.com staff writers
Cancer treatment firm Sirtex Medical is highlighting the results of a multicenter clinical study presented last week at the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco.
January 27, 2013
Previous Page
Page 192 of 464
Next Page